Your browser doesn't support javascript.
loading
Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals.
Zhou, Hang; Kember, Rachel L; Deak, Joseph D; Xu, Heng; Toikumo, Sylvanus; Yuan, Kai; Lind, Penelope A; Farajzadeh, Leila; Wang, Lu; Hatoum, Alexander S; Johnson, Jessica; Lee, Hyunjoon; Mallard, Travis T; Xu, Jiayi; Johnston, Keira J A; Johnson, Emma C; Nielsen, Trine Tollerup; Galimberti, Marco; Dao, Cecilia; Levey, Daniel F; Overstreet, Cassie; Byrne, Enda M; Gillespie, Nathan A; Gordon, Scott; Hickie, Ian B; Whitfield, John B; Xu, Ke; Zhao, Hongyu; Huckins, Laura M; Davis, Lea K; Sanchez-Roige, Sandra; Madden, Pamela A F; Heath, Andrew C; Medland, Sarah E; Martin, Nicholas G; Ge, Tian; Smoller, Jordan W; Hougaard, David M; Børglum, Anders D; Demontis, Ditte; Krystal, John H; Gaziano, J Michael; Edenberg, Howard J; Agrawal, Arpana; Justice, Amy C; Stein, Murray B; Kranzler, Henry R; Gelernter, Joel.
Afiliación
  • Zhou H; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA. hang.zhou@yale.edu.
  • Kember RL; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA. hang.zhou@yale.edu.
  • Deak JD; Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT, USA. hang.zhou@yale.edu.
  • Xu H; Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.
  • Toikumo S; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Yuan K; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Lind PA; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Farajzadeh L; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Wang L; Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.
  • Hatoum AS; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Johnson J; Stanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Lee H; Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Mallard TT; Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Xu J; School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
  • Johnston KJA; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
  • Johnson EC; Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark.
  • Nielsen TT; The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
  • Galimberti M; Center for Genomics and Personalized Medicine, Aarhus, Denmark.
  • Dao C; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Levey DF; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Overstreet C; Department of Psychological and Brain Sciences, Washington University in St. Louis, Saint Louis, MO, USA.
  • Byrne EM; Pamela Sklar Division of Psychiatric Genomics, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gillespie NA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Gordon S; Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Hickie IB; Stanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Whitfield JB; Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Xu K; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Zhao H; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Huckins LM; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Davis LK; Department of Psychiatry, Washington University School of Medicine, Saint Louis, MO, USA.
  • Sanchez-Roige S; Department of Biomedicine - Human Genetics, Aarhus University, Aarhus, Denmark.
  • Madden PAF; The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
  • Heath AC; Center for Genomics and Personalized Medicine, Aarhus, Denmark.
  • Medland SE; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Martin NG; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Ge T; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Smoller JW; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Hougaard DM; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Børglum AD; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Demontis D; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Krystal JH; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Gaziano JM; Child Health Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
  • Edenberg HJ; Institute for Psychiatric and Behavioral Genetics, Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
  • Agrawal A; Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Justice AC; Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Stein MB; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
  • Kranzler HR; Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.
  • Gelernter J; Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.
Nat Med ; 29(12): 3184-3192, 2023 Dec.
Article en En | MEDLINE | ID: mdl-38062264
ABSTRACT
Problematic alcohol use (PAU), a trait that combines alcohol use disorder and alcohol-related problems assessed with a questionnaire, is a leading cause of death and morbidity worldwide. Here we conducted a large cross-ancestry meta-analysis of PAU in 1,079,947 individuals (European, N = 903,147; African, N = 122,571; Latin American, N = 38,962; East Asian, N = 13,551; and South Asian, N = 1,716 ancestries). We observed a high degree of cross-ancestral similarity in the genetic architecture of PAU and identified 110 independent risk variants in within- and cross-ancestry analyses. Cross-ancestry fine mapping improved the identification of likely causal variants. Prioritizing genes through gene expression and chromatin interaction in brain tissues identified multiple genes associated with PAU. We identified existing medications for potential pharmacological studies by a computational drug repurposing analysis. Cross-ancestry polygenic risk scores showed better performance of association in independent samples than single-ancestry polygenic risk scores. Genetic correlations between PAU and other traits were observed in multiple ancestries, with other substance use traits having the highest correlations. This study advances our knowledge of the genetic etiology of PAU, and these findings may bring possible clinical applicability of genetics insights-together with neuroscience, biology and data science-closer.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Grupos Raciales / Alcoholismo Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Grupos Raciales / Alcoholismo Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...